Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,284 | 5,277 | -6,367 | N/A | N/A |
| Depreciation Amortization | 1,311 | 2,283 | 889 | N/A | N/A |
| Accounts receivable | 1,663 | -896 | -8,408 | N/A | N/A |
| Accounts payable and accrued liabilities | 169 | 557 | 197 | N/A | N/A |
| Other Working Capital | 9,148 | 44 | -7,359 | N/A | N/A |
| Other Operating Activity | 7,858 | -250 | 8,753 | 0 | 0 |
| Operating Cash Flow | $9,865 | $7,015 | $-12,295 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,748 | -937 | -277 | N/A | N/A |
| Investing Cash Flow | $-4,748 | $-937 | $-277 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 13,471 | 5,418 | N/A | N/A |
| Debt Repayment | -27,359 | -1,791 | 0 | N/A | N/A |
| Common Stock Issued | 333,249 | 76,559 | 38 | N/A | N/A |
| Other Financing Activity | 0 | 49 | 10,383 | 0 | 0 |
| Financing Cash Flow | $305,890 | $88,288 | $15,839 | $N/A | $N/A |
| Beginning Cash Position | 98,845 | 4,479 | 1,212 | N/A | N/A |
| End Cash Position | 409,852 | 98,845 | 4,479 | N/A | N/A |
| Net Cash Flow | $311,007 | $94,366 | $3,267 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,865 | 7,015 | -12,295 | N/A | N/A |
| Capital Expenditure | -4,751 | -937 | -277 | N/A | N/A |
| Free Cash Flow | 5,114 | 6,078 | -12,572 | 0 | 0 |